Every woman who lives past midlife will experience menopause, which, by definition, is complete cessation of ovarian function. This process might occur spontaneously (natural …
SS Faubion, CJ Crandall, L Davis… - …, 2022 - ingentaconnect.com
“The 2022 Hormone Therapy Position Statement of The North American Menopause Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …
Alzheimer disease (AD) is characterized by wide heterogeneity in cognitive and behavioural syndromes, risk factors and pathophysiological mechanisms. Addressing this phenotypic …
RA Nebel, NT Aggarwal, LL Barnes, A Gallagher… - Alzheimer's & …, 2018 - Elsevier
Introduction Precision medicine methodologies and approaches have advanced our understanding of the clinical presentation, development, progression, and management of …
IT Lott, E Head - Nature Reviews Neurology, 2019 - nature.com
Virtually all adults with Down syndrome (DS) show the neuropathological changes of Alzheimer disease (AD) by the age of 40 years. This association is partially due to …
RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016 recommendations on women's midlife health and menopause hormone therapy (MHT) to …
MM Mielke - The Psychiatric times, 2018 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) dementia is the most common form of dementia, comprising 60 to 70 percent of all cases. AD is a progressive neurodegenerative disease that causes memory …
CJ Pike - Journal of neuroscience research, 2017 - Wiley Online Library
Men and women exhibit differences in the development and progression of Alzheimer's disease (AD). The factors underlying the sex differences in AD are not well understood. This …
Major depressive disorder is a common psychiatric disorder associated with marked suffering, morbidity, mortality, and cost. The World Health Organization projects that by 2030 …